Disparities in access to Dolutegravir in children, adolescents and young adults aged 0-24 years living with HIV in West Africa. A cohort analysis.
Sophie DesmondeJoycelyn Assimeng DameKaren MalatesteAgatha N DavidMadeleine Amorissani-FolquetSylvie N'GbecheMariam SyllaElom TakassiKouadio KouakouLehila Bagnan TossaCaroline YonabaValeriane Leroynull nullPublished in: medRxiv : the preprint server for health sciences (2024)
Training and updating guidance for healthcare workers is essential to ensure universal access to DTG, especially for girls, where unequity begins at 5 years.Efforts to improve access to DTG in West Africa require multifaceted interventions including healthcare infrastructure improvement and facilitation of pediatric antiretroviral forecasting and planification.